首页 | 本学科首页   官方微博 | 高级检索  
检索        

急性坏死性胰腺炎大鼠胰生长抑素受体的变化与奥曲肽治疗的作用机制
引用本文:吴建新,袁耀宗,徐家裕,夏宗勤,秦兰芬,郑震林.急性坏死性胰腺炎大鼠胰生长抑素受体的变化与奥曲肽治疗的作用机制[J].中华医学杂志,2001,81(12):740-743.
作者姓名:吴建新  袁耀宗  徐家裕  夏宗勤  秦兰芬  郑震林
作者单位:1. 上海市第一人民医院消化内科,
2. 上海第二医科大学瑞金医院消化内科
3. 上海第二医科大学实验核医学研究室
4. 上海第二医科大学病理教研室
5. 复旦大学
基金项目:国家自然科学基金资助项目(39570891)
摘    要:目的研究急性坏死性胰腺炎(ANP)时胰生长抑素受体(SSTR)的表达、胰组织血流改变及其与二十碳烯酸代谢的关系,探讨生长抑素类似剂奥曲肽治疗ANP的作用机制。方法以牛磺胆酸钠胰胆管注射诱发大鼠ANP模型,作125I-生长抑素-14受体放射配基结合实验,原位杂交检测胰组织SSTR2mRNA表达,组织血流仪测量胰组织血流,放免法检测血浆二十碳烯酸代谢物等。结果正常大鼠胰SSTR水平为110±58fmol/mg膜蛋白;ANP发病后3、6、12h,胰SSTR显著减低,SSTR2mRNA原位杂交信号显著减弱,胰组织血流明显降低,血栓素B2显著增高;奥曲肽给药组胰组织血流降低和二十碳烯酸异常代谢显著矫正,病理损害减轻。结论急性坏死性胰腺炎时胰组织SSTR表达显著降低。因此,生长抑素类似剂治疗ANP的机制可能主要与矫正二十碳烯酸异常代谢、改善胰组织微循环等有关,而受体介导的抑酶作用则是次要的。

关 键 词:急性坏死性胰腺炎  奥曲肽  胰生长抑素受体  治疗
修稿时间:2000年12月12

Changes of somatostatin receptor of pancreas and effectiveness of octreotide on acute necrotizng pancreatitis in mice
J Wu,Y Yuan,J Xu.Changes of somatostatin receptor of pancreas and effectiveness of octreotide on acute necrotizng pancreatitis in mice[J].National Medical Journal of China,2001,81(12):740-743.
Authors:J Wu  Y Yuan  J Xu
Institution:Department of Gastroenterology, Shanghai First People's Hospital, Shanghai 200080, China.
Abstract:OBJECTIVE: Changes of somamtostatin receptor (SSTR) of pancreas, pancreatic blood flow and its relationship to metabolism of eicosanoids were investigated in order to elucidate the effectiveness of octreotide, an analogue of somatostatin, in acute necrotizng pancreatitis (ANP). METHODS: Rats with ANP were triggered with sodium taurocholate via pancreatobillary duct; SSTR was detected by radioligand binding assay (RBA) with (125)I-somatostatiin-14; in Situ hybridization was employed in analysis of SSTR2 mRNA of pancreas; pancreatic blood flow was determined with tissue blood flowmeter and metabolites of eicosanoids were analyzed with radioimmunoassay. RESULTS: The level of SSTR of pancreas was 110 +/- 58 fmol/mg.protein in normal rats. Significant decrease of SSTR was shown at 3, 6, 12 hours after onset of ANP and of the signals of SSTR2 mRNA by in situ hybridization as well. Pancreatic blood flow was reduced while thromboxin-2 was increased significantly in the course of ANP. But in the group of ANP treated with octreotide, both the decrease of pancreatic blood flow and abnormal metabolism of eicosanoids were corrected, and the pathologic damages were reduced. CONCLUSION: SSTR of pancreas is significantly reduced in ANP. Therefore, correction of abnormal metabolism of eicosanoids and improvement of pancreatic microcirculation may be the major mechanism of somatostatin analogues in treatment of ANP while inhibition of pancreatic enzymes via receptors may play a minor role.
Keywords:Pancreatitis  acute necrotizing  Octreotide  Receptor  somatostatin
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号